Cargando…
Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
Rift Valley fever virus (RVFV) is a mosquito-borne hemorrhagic fever virus affecting both humans and animals with severe morbidity and mortality and is classified as a potential bioterror agent due to the possible aerosol transmission. At present there is no human vaccine or antiviral therapy availa...
Autores principales: | Islam, Md. Koushikul, Strand, Mårten, Saleeb, Michael, Svensson, Richard, Baranczewski, Pawel, Artursson, Per, Wadell, Göran, Ahlm, Clas, Elofsson, Mikael, Evander, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792431/ https://www.ncbi.nlm.nih.gov/pubmed/29386590 http://dx.doi.org/10.1038/s41598-018-20362-9 |
Ejemplares similares
-
Antiviral Activity of Benzavir-2 against Emerging Flaviviruses
por: Gwon, Yong-Dae, et al.
Publicado: (2020) -
Structural Modifications and Biological Evaluations
of Rift Valley Fever Virus Inhibitors Identified from Chemical Library
Screening
por: Islam, Koushikul, et al.
Publicado: (2022) -
The 2007 Rift Valley Fever Outbreak in Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2011) -
A need for One Health approach – lessons learned from outbreaks of Rift Valley fever in Saudi Arabia and Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2014) -
Ethnic groups’ knowledge, attitude and practices and Rift Valley fever exposure in Isiolo County of Kenya
por: Affognon, Hippolyte, et al.
Publicado: (2017)